Recent Updates
Recently added Catalysts

Vdrive Lasso navigation, Manual Lasso navigation

Phase 3

Atrial Fibrillation | Unknown | Cardiovascular |Stereotaxis, Inc.|Last Updated: Jul 1, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment120
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01656772Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures StudyPHASE3 COMPLETED 120Aug 1, 2012Dec 1, 2013Jul 1, 20155 United States, Belgium +1
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
The Primary Effectiveness Endpoint is the Successful Navigation and EGM Recording of Each Pre-specified Pulmonary Vein Per Procedure Between Both the Control and the Investigational Device Groups.
Peri-procedural

Success was navigating and sensing by obtaining an EGM at the pre-specified targeted PVs. The null hypothesis was to be tested at the α = 0.05 significance level using a test statistic Z based on the Farrington and Manning likelihood score statistic with adjustment to take into account the correlation between multiple observations (PVs) on the same subject. The null hypothesis was to be rejected if Z \> 1.645 or, equivalently, if the corresponding p-value was less than 0.05.

Safety Outcome to be Assessed by Comparing the Rate of Adjudicated Serious Adverse Events Within 7 Days of the Procedure Between Both the Control and the Investigational Device Groups.
7 days Follow-up

The Vdrive will allow physicians to manipulate compatible circular mapping catheters while maintaining a safety profile that is not inferior to manual circular catheter navigation. The one-sided null hypothesis was to be tested at the α = 0.05 significance level using a standard unpooled asymptotically normal test statistic. The null hypothesis was to be rejected if Z \< -1.7046 or, equivalently, if the corresponding p-value was less than 0.05.

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Manual Lasso navigationACTIVE_COMPARATORUse of conventional manual navigation techniques with the Lasso catheter
Vdrive Lasso navigationEXPERIMENTALUse of the Vdrive to remotely and robotically control the manipulation of a Lasso catheter
Interventions
NameTypeDescription
Vdrive Lasso navigationDEVICERemote robotic Lasso navigation
Manual Lasso navigationPROCEDUREManually maneuver a Lasso catheter
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 80 Years
SexALL
Healthy VolunteersNo
Study Sites5

Inclusion Criteria: * Left atrial AF ablation procedure requiring the use of a Lasso mapping catheter * Subject must be at least 18 years of age * Subject must be male, female of no childbearing potential, or a female that has a negative pregnancy test prior to randomization Exclusion Criteria: *...

Countries:United StatesBelgiumGermany
Unlock Eligibility Criteria